The estimated Net Worth of Todd S. Young is at least 2.35 百万$ dollars as of 3 August 2020. Mr. Young owns over 7,000 units of Elanco Animal Health Inc stock worth over 72,400$ and over the last 17 years he sold ELAN stock worth over 0$. In addition, he makes 2,274,130$ as Chief Financial Officer、 Executive Vice President at Elanco Animal Health Inc.
Todd has made over 2 trades of the Elanco Animal Health Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently he bought 7,000 units of ELAN stock worth 167,370$ on 3 August 2020.
The largest trade he's ever made was buying 10,000 units of Elanco Animal Health Inc stock on 4 September 2019 worth over 265,700$. On average, Todd trades about 773 units every 15 days since 2008. As of 3 August 2020 he still owns at least 5,000 units of Elanco Animal Health Inc stock.
You can see the complete history of Mr. Young stock trades at the bottom of the page.
Todd S. Young is Chief Financial Officer, Executive Vice President of the Company. Prior to joining Elanco, Mr. Young was the Executive Vice President and Chief Financial Officer at ACADIA Pharmaceuticals, a biopharmaceutical company, since 2016. Prior to his time at ACADIA, Mr. Young served as Senior Vice President and Treasurer leading the creation of a capital structure for Baxalta, a biopharmaceutical company, up until its acquisition by Shire in June 2016. Prior to Baxalta, Mr. Young worked for over 14 years at Baxter International Inc., a health care company, in multiple leadership roles, including Corporate Vice President and Treasurer, Vice President, International Finance, and Vice President, Global Financial Planning and Analysis.
As the Chief Financial Officer、 Executive Vice President of Elanco Animal Health Inc, the total compensation of Todd Young at Elanco Animal Health Inc is 2,274,130$. There are 5 executives at Elanco Animal Health Inc getting paid more, with Jeffrey Simmons having the highest compensation of 15,801,800$.
Todd Young is 48, he's been the Chief Financial Officer、 Executive Vice President of Elanco Animal Health Inc since 2018. There are 26 older and 1 younger executives at Elanco Animal Health Inc. The oldest executive at Elanco Animal Health Inc is R. David Hoover, 74, who is the Independent Chairman of the Board.
Todd's mailing address filed with the SEC is C/O ELANCO ANIMAL HEALTH INCORPORATED, 2500 INNOVATION WAY, GREENFIELD, IN, 46140.
Over the last 6 years, insiders at Elanco Animal Health Inc have traded over 1,626,280,000$ worth of Elanco Animal Health Inc stock and bought 657,104 units worth 14,225,149$ . The most active insiders traders include Aktiengesellschaft Bayer Wo...、Scott D.Sachem Head Capital...、R David Hoover. On average, Elanco Animal Health Inc executives and independent directors trade stock every 38 days with the average trade being worth of 14,011,833$. The most recent stock trade was executed by Michael J Harrington on 22 August 2024, trading 3,500 units of ELAN stock currently worth 51,975$.
elanco is a global animal health company. our vision: food and companionship enriching life. elanco fulfills this vision through three primary pursuits: - helping deliver a safe, more affordable, more abundant food supply by improving the health and performance of animals - helping pets live longer, healthier, higher-quality lives - improving food safety elanco employees are empowered to preserve elanco’s common culture of humility, discipline and involvement. we have a responsibility to connect and contribute to our cause, to be passionate about delivering solutions and value to our customers, and to embrace opportunities for personal and professional growth and development. through innovative products, quality systems and a shared vision, elanco strives daily to enhance animal health—and enrich the lives of people worldwide.
Elanco Animal Health Inc executives and other stock owners filed with the SEC include: